US 2022/0031651 A1 · COMPOSITION COMPRISING FERROUS AMINO ACID PARTICLES AND METHOD FOR TREATING OR AMELIORATING PANCRES-RELATED DISEASE USING THE SAME

Abstract

The present invention provides a composition, comprising ferrous amino acid chelate particles sintered from ferrous amino acid chelate, wherein the average particle size of the ferrous amino acid chelate particles ranges from 500 nm to 2600 nm, and the average molecular weight of the particles ranges from 1,500 Dalton to 600,000 Dalton. Besides, the present invention can be used for manufacturing a medicament for treating or ameliorating a pancreas-related disease, wherein the medicament comprises an effective amount of the composition and a pharmaceutically acceptable carrier.

Claims12

Dependent claims

A composition, comprising ferrous amino acid chelate particles sintered from ferrous amino acid chelate, wherein the average particle size of the ferrous amino acid chelate particles ranges from 500 nm to 2600 nm, and the average molecular weight ranges from 1,500 Dalton to 600,000 Dalton.

Dependencies are inferred from the claim text.

Facts

Application

16/965,181Filed 20 Dec 2018

Published

3 Feb 2022

Term ends

Not estimatedThe source records don’t support an estimate.

Classification9 codes

A61K 31/295
Compounds containing heavy metals: iron group metal compounds
A61K 31/7068
Containing condensed or non-condensed pyrimidines: having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
A61K 33/26
Heavy metals; Compounds thereof: iron; Compounds thereof
A61P 1/18
Drugs for disorders of the alimentary tract or the digestive system: for pancreatic disorders, e.g. pancreatic enzymes

Composition comprising ferrous amino acid particles and method for treating or ameliorating pancres-related disease using the same

Life of this patent

Composition comprising ferrous amino acid particles and method for treating or ameliorating pancres-related disease using the same

Life of this patent

Abstract

Claims12